您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报 (医学版) ›› 2024, Vol. 62 ›› Issue (9): 55-60.doi: 10.6040/j.issn.1671-7554.0.2024.0271

• 主动脉疾病基础与临床研究进展专刊—研究进展 • 上一篇    

腹主动脉瘤腔内修复术后Ⅱ型内漏的预防及治疗进展

范立彬1,2,张鸿坤1   

  1. 1.浙江大学医学院附属第一医院血管外科, 浙江 杭州 310003;2.绍兴文理学院附属医院血管疝外科, 浙江 绍兴 312000
  • 发布日期:2024-10-10
  • 通讯作者: 张鸿坤. E-mail:doczhk@163.com

Progress in prevention and treatment of type Ⅱ endoleak after endovascular abdominal aortic aneurysm repair

FAN Libin1,2, ZHANG Hongkun1   

  1. 1. Department of Vascular Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310003, Zhejiang, China;
    2. Department of Vascular and Hernia Surgery, Affiliated Hospital of Shaoxing University, Shaoxing 312000, Zhejiang, China
  • Published:2024-10-10

摘要: 腹主动脉瘤是严重的血管外科疾病,可危及生命,其发病率逐年上升。腹主动脉瘤腔内修复术(endovascular aneurysm repair, EVAR)是目前肾下型腹主动脉瘤(abdominal aortic aneurysm, AAA)最广泛使用的治疗方法。Ⅱ型内漏是EVAR术后最常见的并发症,也是术后二次干预的主要原因,然而目前对Ⅱ型内漏的自然转归及治疗尚存在争议。本文拟通过对Ⅱ型内漏预防及治疗的研究进展进行文献回顾,为临床决策提供参考。

关键词: 腹主动脉瘤, 腔内修复, Ⅱ型内漏, 预防, 治疗

Abstract: Abdominal aortic aneurysm(AAA)is a life-threatening disease and its incidence is increasing year by year. Endovascular aneurysm repair(EVAR)is currently the most widely used treatment for infrarenal abdominal aortic aneurysms(AAA). Type Ⅱ endoleak is the most common complication after EVAR and the main reason for secondary postoperative intervention, however, the natural outcome and treatment of type Ⅱ endoleak are still controversial. This paper reviewed the literature on the research progress in the prevention and treatment of type Ⅱ endoleak to provide a reference for clinical decision-making.

Key words: Abdominal aortic aneurysm, Endovascular repair, Type Ⅱ endoleak, Prevention, Treatment

中图分类号: 

  • R543.1+6
[1] Summers KL, Kerut EK, Sheahan CM, et al. Evaluating the prevalence of abdominal aortic aneurysms in the United States through a national screening database[J]. J Vasc Surg, 2021, 73(1): 61-68.
[2] 王颖, 顾慧, 于鑫鑫, 等. 71例腹主动脉瘤的基线CT特征与病变进展的相关性[J]. 山东大学学报(医学版), 2022, 60(10): 62-67. WANG Ying, GU Hui, YU Xinxin, et al. Correlation between baseline CT features and progression of abdominal aortic aneurysm in 71 cases[J]. Journal of Shandong University(Health Sciences), 2022, 60(10): 62-67.
[3] Cifuentes S, Mendes BC, Tabiei A, et al. Management of endoleaks after elective infrarenal aortic endovascular aneurysm repair: a review[J]. JAMA Surg, 2023, 158(9): 965-973.
[4] Sun Y, Cai HB, Yang D, et al. Volumetric analysis of effectiveness of embolization for preventing type II endoleaks following endovascular aortic aneurysm repair[J]. J Vasc Surg, 2023, 77(3): 752-759.
[5] 中华医学会外科学分会血管外科学组. 腹主动脉瘤诊断和治疗中国专家共识(2022版)[J]. 中国实用外科杂志, 2022, 42(4): 380-387. Chinese Society for Vascular Surgery, Chinese Society of Surgery, Chinese Medical Association. Chinese expert consensus on the diagnosis and treatment of abdominal aortic aneurysm(2022 edition)[J]. Chinese Journal of Practical Surgery, 2022, 42(4): 380-387.
[6] Akmal MM, Pabittei DR, Prapassaro T, et al. A systematic review of the current status of interventions for type II endoleak after EVAR for abdominal aortic aneurysms[J]. Int J Surg, 2021, 95: 106138. doi:10.1016/j.ijsu.2021.106138.
[7] Dijkstra ML, Zeebregts CJ, Verhagen HJM, et al. Incidence, natural course, and outcome of type II endoleaks in infrarenal endovascular aneurysm repair based on the ENGAGE registry data[J]. J Vasc Surg, 2020, 71(3): 780-789.
[8] Lal BK, Zhou W, Li ZY, et al. Predictors and outcomes of endoleaks in the Veterans Affairs Open Versus Endovascular Repair(OVER)Trial of abdominal aortic aneurysms[J]. J Vasc Surg, 2015, 62(6): 1394-1404.
[9] Seike Y, Matsuda H, Shimizu H, et al. Nationwide analysis of persistent type II endoleak and late outcomes of endovascular abdominal aortic aneurysm repair in Japan: a propensity-matched analysis[J]. Circulation, 2022, 145(14): 1056-1066.
[10] Guo Q, Zhao JC, Ma YK, et al. A meta-analysis of translumbar embolization versus transarterial embolization for type II endoleak after endovascular repair of abdominal aortic aneurysm[J]. J Vasc Surg, 2020, 71(3): 1029-1034.
[11] Cheadle GA, Dwivedi AJ, Wayne EJ, et al. Transcaval coil embolization of type 2 endoleak after endovascular aortic repair: an institutional review[J]. Vasc Endovascular Surg, 2024, 58(1): 47-53.
[12] Knappich C, Kirchhoff F, Fritsche MK, et al. Endovascular aortic repair with sac embolization for the prevention of type II endoleaks(the EVAR-SE study): study protocol for a randomized controlled multicentre study in Germany[J]. Trials, 2024, 25(1): 17.
[13] Madigan MC, Singh MJ, Chaer RA, et al. Occult type Ⅰ or Ⅲ endoleaks are a common cause of failure of type Ⅱ endoleak treatment after endovascular aortic repair[J]. J Vasc Surg, 2019, 69(2): 432-439.
[14] 姚陈, 孙云昊. 腹主动脉瘤腔内修复术后Ⅱ型内漏的长期临床意义和治疗进展[J]. 临床外科杂志, 2023, 31(12): 1116-1119. YAO Chen, SUN Yunhao. Long term clinical significance and treatment progress of type Ⅱ endoleaks after endovascular treatment of aortic aneurysm[J]. Journal of Clinical Surgery, 2023, 31(12):1116-1119.
[15] DOria M, Mastrorilli D, Ziani B. Natural history, diagnosis, and management of type Ⅱ endoleaks after endovascular aortic repair: review and update[J]. Ann Vasc Surg, 2020, 62: 420-431. doi:10.1016/j.avsg.2019.04.048.
[16] Kawada H, Goshima S, Sakurai K, et al. Utility of noncontrast magnetic resonance angiography for aneurysm follow-up and detection of endoleaks after endovascular aortic repair[J]. Korean J Radiol, 2021, 22(4): 513-524.
[17] Katada Y. Recent update of endovascular type 2 endoleak management[J]. Interv Radiol, 2020, 5(3): 114-119.
[18] Karaolanis GI, Antonopoulos CN, Georgakarakos E, et al. Colour duplex and/or contrast-enhanced ultrasound compared with computed tomography angiography for endoleak detection after endovascular abdominal aortic aneurysm repair: a systematic review and meta-analysis[J]. J Clin Med, 2022, 11(13): 3628.
[19] Frenzel F, Kubale R, Massmann A, et al. Artifacts in contrast-enhanced ultrasound during follow-up after endovascular aortic repair: Impact on endoleak detection in comparison with computed tomography angiography[J]. Ultrasound Med Biol, 2021, 47(3): 488-498.
[20] Voutsinas N, Kim E, Lookstein RA. Predictive factors and strategies to prevent the development of type 2 endoleaks following endovascular aneurysm repair[J]. Semin Intervent Radiol, 2020, 37(4): 389-394.
[21] Chen JX, Stavropoulos SW. Type 2 endoleak management[J]. Semin Intervent Radiol, 2020, 37(4): 365-370.
[22] van Marrewijk CJ, Fransen G, Laheij RJ, et al. Is a type II endoleak after EVAR a harbinger of risk? Causes and outcome of open conversion and aneurysm rupture during follow-up[J]. Eur J Vasc Endovasc Surg, 2004, 27(2): 128-137.
[23] Guo Q, Du XJ, Zhao JC, et al. Prevalence and risk factors of type II endoleaks after endovascular aneurysm repair: a meta-analysis[J]. PLoS One, 2017, 12(2): e0170600. doi:10.1371/journal.pone.0170600.
[24] Ide T, Masada K, Kuratani T, et al. Risk analysis of aneurysm sac enlargement caused by type Ⅱ endoleak after endovascular aortic repair[J]. Ann Vasc Surg, 2021, 77: 208-216. doi:10.1016/j.avsg.2021.06.013.
[25] Ward TJ, Cohen S, Patel RS, et al. Anatomic risk factors for type-2 endoleak following EVAR: a retrospective review of preoperative CT angiography in 326 patients[J]. Cardiovasc Intervent Radiol, 2014, 37(2): 324-328.
[26] 韦金豆, 杨晗, 胡明, 等. 腹主动脉瘤腔内修复术后内漏研究现状[J]. 中华血管外科杂志, 2023, 8(1): 64-68. WEI Jindou, YANG Han, HU Ming, et al. Research status of endoleak after endovascular repair of abdominal aortic aneurysm[J]. Chinese Journal of Vascular Surgery, 2023, 8(1): 64-68.
[27] 邱昌涛, 李玥锦, 李柔刚, 等. 腹主动脉瘤腔内修复术后Ⅱ型内漏的预防及治疗研究进展[J]. 医学综述, 2022, 28(13): 2619-2624. QIU Changtao, LI Yuejin, LI Rougang, et al. Progress in prevention and treatment of type Ⅱ endoleaks after endovascular aneurysm repair[J]. Medical Recapitulate, 2022, 28(13): 2619-2624.
[28] Chaikof EL, Dalman RL, Eskandari MK, et al. The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm[J]. J Vasc Surg, 2018, 67(1): 2-77.
[29] Wanhainen A, Verzini F, van Herzeele I, et al. Editors choice- European society for vascular surgery(ESVS)2019 clinical practice guidelines on the management of abdominal aorto-iliac artery aneurysms[J]. Eur J Vasc Endovasc Surg, 2019, 57(1): 8-93.
[30] Ameli-Renani S, Pavlidis V, Morgan RA. Secondary endoleak management following TEVAR and EVAR[J]. Cardiovasc Intervent Radiol, 2020, 43(12): 1839-1854.
[31] Heidemann F, Rohlffs F, Tsilimparis N, et al. Transcaval embolization for type Ⅱ endoleak after endovascular aortic repair of infrarenal, juxtarenal, and type Ⅳ thoracoabdominal aortic aneurysm[J]. J Vasc Surg, 2021, 74(1): 38-44.
[32] Jouhannet C, Alsac JM, Julia P, et al. Reinterventions for type 2 endoleaks with enlargement of the aneurismal sac after endovascular treatment of abdominal aortic aneurysms[J]. Ann Vasc Surg, 2014, 28(1): 192-200.
[33] Shang T, Liu L, Zhou X, et al. Percutaneous contrast-enhanced ultrasound-guided transabdominal sac embolization is an effective technique for treating complicated type II endoleaks after endovascular aneurysm repair[J]. J Vasc Surg, 2022, 75(6): 1918-1925.
[34] Stoecker JB, Glaser JD. Review of type III endoleaks[J]. Semin Intervent Radiol, 2020, 37(4): 371-376.
[35] Mazzaccaro D, Mazzeo G, Zuccon G, et al. Factors affecting the occurrence of proximal endoleak after endovascular abdominal aortic repair for abdominal aneurysms[J]. J Int Med Res, 2020, 48(11): 300060520971515. doi:10.1177/0300060520971515.
[36] Blakeslee-Carter J, Beck A, Spangler E. Occurrence and outcomes of type 3 endoleaks in endovascular aortic repair within the Vascular Quality Initiative database[J]. BMJ Surg Interv Health Technol, 2020, 2(1): e000054. doi:10.1136/bmjsit-2020-000054.
[37] Takahashi B, Kamiya S, Ohta K, et al. Intraoperative findings of an atypical type II endoleak from an artery within the aneurysmal wall after endovascular aneurysm repair[J]. Ann Vasc Dis, 2020, 13(4): 457-460.
[38] Schmitz-Rixen T, Böckler D, Vogl TJ, et al. Endovascular and open repair of abdominal aortic aneurysm[J]. Dtsch Arztebl Int, 2020, 117(48): 813-819.
[39] Kontopodis N, Galanakis N, Tzartzalou I, et al. An update on the improvement of patient eligibility with the use of new generation endografts for the treatment of abdominal aortic aneurysms[J]. Expert Rev Med Devices, 2020, 17(11): 1231-1238.
[40] Yu HYH, Lindström D, Wanhainen A, et al. An updated systematic review and meta-analysis of pre-emptive aortic side branch embolization to prevent type Ⅱ endoleaks after endovascular aneurysm repair[J]. J Vasc Surg, 2023, 77(6): 1815-1821.
[41] Niklas N, Malec M, Gutowski P, et al. Effectiveness of inferior mesenteric artery embolization on type Ⅱ endoleak-related complications after endovascular aortic repair(EVAR): systematic review and meta-analysis[J]. J Clin Med, 2022, 11(18): 5491.
[42] Yu HYH, Lindström D, Wanhainen A, et al. Systematic review and meta-analysis of prophylactic aortic side branch embolization to prevent type Ⅱ endoleaks[J]. J Vasc Surg, 2020, 72(5): 1783-1792.
[43] Samura M, Morikage N, Otsuka R, et al. Endovascular aneurysm repair with inferior mesenteric artery embolization for preventing type Ⅱ endoleak: a prospective randomized controlled trial[J]. Ann Surg, 2020, 271(2): 238-244.
[1] 李彦明 李冬青 陈鹏 张科峰. 聚乙丙交酯膜预防硬膜外瘢痕粘连的实验研究[J]. 山东大学学报(医学版), 2209, 47(6): 33-.
[2] 巩性军,吴树明,张供,李守先,庞昕焱. 无顶冠状静脉窦综合征的诊断和外科治疗[J]. 山东大学学报(医学版), 2209, 47(6): 129-.
[3] 陈忠,王盛. 主动脉疾病治疗现状及思考[J]. 山东大学学报 (医学版), 2024, 62(9): 1-6.
[4] 林长泼,符伟国. Stanford B型主动脉夹层的诊疗进展[J]. 山东大学学报 (医学版), 2024, 62(9): 7-12.
[5] 卫任,郭伟. 腹主动脉瘤腔内治疗现状[J]. 山东大学学报 (医学版), 2024, 62(9): 13-18.
[6] 王伦常,覃淇,舒畅. 创伤性B型主动脉夹层的诊疗进展[J]. 山东大学学报 (医学版), 2024, 62(9): 19-25.
[7] 史潇兮,辛世杰. 腹主动脉瘤的开放手术[J]. 山东大学学报 (医学版), 2024, 62(9): 26-29.
[8] 杨建平,管圣,方青波,慈红波,戈小虎. 钝性胸主动脉损伤的诊治进展[J]. 山东大学学报 (医学版), 2024, 62(9): 36-41.
[9] 霍正坤,孔祥骞,吴学君. 感染性主动脉瘤诊疗进展[J]. 山东大学学报 (医学版), 2024, 62(9): 42-48.
[10] 周永康,孙境,张帅,钱向阳. 胸腹主动脉瘤开放修复脊髓保护策略的研究进展[J]. 山东大学学报 (医学版), 2024, 62(9): 49-54.
[11] 甘琦晴,刘现虎,苟园,杨彬. 主动脉夹层合并截瘫诊断与治疗2例并文献复习[J]. 山东大学学报 (医学版), 2024, 62(8): 101-106.
[12] 孙丛丛,崔文静,张锦涛,张东,刘晓菲,潘云,亓倩,徐嘉蔚,曾荣,郭红喜,董亮. 铁死亡在支气管哮喘气道重塑中的作用[J]. 山东大学学报 (医学版), 2024, 62(7): 1-9.
[13] 张学宇,张学海,孙文青,刘晗,姜金波,刘寒,李远,陈晓梅. 重症新型冠状病毒肺炎伴侵袭性肺曲霉病及反复致命性消化道出血1例[J]. 山东大学学报 (医学版), 2024, 62(7): 56-61.
[14] 王凤燕,梁振宇,李雪萍,陈荣昌. 慢性阻塞性肺疾病近年临床研究热点[J]. 山东大学学报 (医学版), 2024, 62(5): 7-15.
[15] 丁伊人,刘婉莹,姚蕾,姚欣. 大环内酯类抗生素治疗哮喘的研究进展[J]. 山东大学学报 (医学版), 2024, 62(5): 21-27.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!